A study pointed out that upregulation of SLC2A3 was associated with decreased OS and DFS in colorectal cancer patients (29), which indicated that SLC2A3 played an important role in the prognosis of CC patients. The gene discussed is SLC2A3; the disease is colorectal cancer.